Company stock · NYSE · USD

RMD

Resmed Inc

—

Price unavailable — company details still show below

Sector: Healthcare
Industry: Health Care
Size: Medium-sized company
Market value: $35.6 billion
Number of shares: 140.6 million
Country: US
Went public: Jun 1, 1995
Exchange: NYSE
Website: resmed.com
Next earnings: 2026-10-29 · After close · analysts’ expected profit per share $2.70

Compare →Earnings calendar →

Price chart Pro

Loading chart…

Company briefing

What RMD is

Plain English context — why the name shows up in the news, and what to watch next.

In plain English

ResMed Inc. makes and sells medical devices that help people sleep, mainly continuous positive airway pressure (CPAP) machines and masks…

Recent headlines

Live company news for RMD — each headline includes a ClearTape brief in plain English; open the original for the full story.

Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?In brief
ResMed has a history of beating earnings estimates and currently has two key factors that suggest it may do so again in its next quarterly report.
Yahoo · Oct 23, 2026
ResMed Set to Report Q1 Earnings: What's in the Cards for the Stock?In brief
ResMed’s Q1 2027 earnings will be influenced by strong demand for sleep devices and new product launches, while the sale of MatrixCare could reduce revenue.
Yahoo · Oct 23, 2026
Learn Why The Bull Case For ResMed (RMD) Could Change Following U.S. Mask LaunchIn brief
ResMed launched the AirTouch F40 CPAP mask in the U.S., a minimalist design that plugs into its myAir and AirView platforms to improve comfort and adherence for sleep apnea patients.
Yahoo · Oct 23, 2026
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseIn brief
ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Yahoo · Oct 22, 2026
Resmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.In brief
Latest addition to Resmed’s growing fabric mask portfolio combines a soft, breathable fabric cushion with a minimalist design for greater comfort and choiceSAN DIEGO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced the U.S.
Yahoo · Oct 19, 2026
ResMed’s Quarterly Earnings Preview: What You Need to KnowIn brief
ResMed is set to release its fiscal Q1 earnings later this month, with analysts forecasting a modest rise in earnings per share.
Yahoo · Oct 15, 2026
mHealth Solutions Market Forecasts Growth from $109.05B (2026) to $275.44B by 2031, Profiling Philips, Medtronic, Abbott, Dexcom, ResMed & 20 Other Key PlayersIn brief
388-Page Report Delivers 2025 Market Share Rankings, Vendor Valuation Metrics and End-User Buying Criteria as Asia Pacific Emerges as the Fastest-Growing RegionDublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "mHealth Solutions Market: Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering.
Yahoo · Oct 13, 2026
ResMed Q4 2026 Earnings Call TranscriptIn brief
ResMed (NYSE:RMD) reported fourth-quarter financial results on Thursday. The transcript from the company's fourth-quarter earnings call has been provided below. Benzinga APIs provide real-time access to earnings
Benzinga · Oct 12, 2026

Same sector

Similar companies · Healthcare

% is today vs yesterday’s close

Latest on this name

Insights & deeper context

Cards about this company show up here when there is news.

No insights yet

Search another name, add RMD to your watchlist, or check back when fresh news hits. If this company also trades in the US, the “Same company” link above opens that listing.

Back to feed →

Company reports

Official filings (US SEC and linked cards)

No filings here yet

Official report cards for RMD will show up here when available.

Broad market indexes (like the S&P 500, a basket of 500 large US companies) are shown through popular funds that track them (for example SPY). Company profile and prices use live market data when available.